Sort
51,593 grants matching “hepatitis”
HIV HCV COINFECTION--ANTIVIRAL THERAPY AND FIBROSIS
$408,641Johns Hopkins University · R01 · FY2002 · DA
Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease
$408,636Irina A. Kirpich · University Of Louisville · R01 · FY2025 · AA
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Role of Fbxo48-mediated AMPK proteostasis in the pathogenesis and treatment of NAFLD
$408,615Michael J. Jurczak · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS
$408,607Duke University · R01 · FY2004 · AG
Molecular Regulation of Apoprotein B Degradation
$408,570Edward A Fisher · New York University School Of Medicine · R01 · FY2010 · HL
Molecular Regulation of Apoprotein B Degradation
$408,570Edward A Fisher · New York University School Of Medicine · R01 · FY2011 · HL
Pulmonary implications of perinatal acetaminophen exposure
$408,563Clyde Jason Wright · University Of Colorado Denver · R01 · FY2022 · HD
Development of Natural Product Leads as Anticancer Therapeutics
$408,562John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
A New Molecular Mechanism to Bioengineering a Liver
$408,538Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Soluble epoxide hydrolase: assessment of in vivo activity and regulation by gut microbiota
$408,530Jang H. Youn · University Of Southern California · R01 · FY2022 · HL
ASPROSIN NEUTRALIZATION AS A NOVEL ANTI-OBESITY TREATMENT
$408,515Atul Chopra · Case Western Reserve University · R01 · FY2018 · DK
Soluble epoxide hydrolase: assessment of in vivo activity and regulation by gut microbiota
$408,510Jang H. Youn · University Of Southern California · R01 · FY2023 · HL
Obesity and Energy Metabolism Core
$408,482Allen S Levine · University Of Minnesota · P30 · FY2010 · DK
INVESTIGATION OF ERBB SIGNALING IN COLORECTAL CANCER DURING LIVER METASTASIS
$408,460David W. Threadgill · Univ Of North Carolina Chapel Hill · P50 · FY2007 · CA
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$408,425Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
Novel Liver Signaling Pathways Controlling Adiposity
$408,414Terry D Hinds · University Of Kentucky · R01 · FY2021 · DK
Waters Xevo TQ-XS system
$408,398Pawel K Lorkiewicz · University Of Louisville · S10 · FY2022 · OD
Hepatic degradation of cytochrome P450 enzymes
$408,393Maria Almira Correia · University Of California, San Francisco · R01 · FY2009 · GM
Effective PET Imaging in Liver Cancer
$408,368Zhenghong Lee · Case Western Reserve University · R01 · FY2012 · CA
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
$408,360Rajan Sah · Washington University · R01 · FY2022 · DK
Structure Function Relationship of Human Apolipoprotein B100
$408,357Nassrin Dashti · University Of Alabama At Birmingham · R01 · FY2012 · HL
Role of HDAC6 in the Regulation of Energy Homeostasis and Leptin Sensitivity
$408,338Roger D Cone · University Of Michigan At Ann Arbor · R01 · FY2021 · DK